Sociedad Americana de Hirudoterapia

Direction de la Pharmacie et du Médicament — République du Mali

Mali DPM · Mali · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Mali's pharmacy / medicine directorate — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Mali
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Mali Code de Santé Publique and amendments
  • ECOWAS Pharmaceutical Regulatory Harmonisation arrangements where applicable

Prescriber Requirements

  • Mali Ordre des Médecins–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Mali DPM registration as applicable; French-language labelling. Standard cold-chain conditions with logistical constraints typical of Sahel distribution.

Import/Export Rules

Mali DPM and Direction Nationale des Services Vétérinaires clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Mali AMO (Assurance Maladie Obligatoire) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate. ECOWAS West-African regulatory harmonisation arrangements have not been independently mapped by ASH for live-organism medical devices.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.